JP2003506480A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003506480A5 JP2003506480A5 JP2001516508A JP2001516508A JP2003506480A5 JP 2003506480 A5 JP2003506480 A5 JP 2003506480A5 JP 2001516508 A JP2001516508 A JP 2001516508A JP 2001516508 A JP2001516508 A JP 2001516508A JP 2003506480 A5 JP2003506480 A5 JP 2003506480A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- solid
- storage
- granules
- cavity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008187 granular material Substances 0.000 description 14
- 238000000034 method Methods 0.000 description 14
- 239000000843 powder Substances 0.000 description 14
- 239000007787 solid Substances 0.000 description 12
- 239000002552 dosage form Substances 0.000 description 11
- 239000007909 solid dosage form Substances 0.000 description 11
- 238000000465 moulding Methods 0.000 description 10
- 239000013543 active substance Substances 0.000 description 9
- 239000006184 cosolvent Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99810738.7 | 1999-08-17 | ||
| EP99810738 | 1999-08-17 | ||
| PCT/EP2000/007934 WO2001012161A1 (en) | 1999-08-17 | 2000-08-14 | Rapidly dissolving dosage form and process for making same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003506480A JP2003506480A (ja) | 2003-02-18 |
| JP2003506480A5 true JP2003506480A5 (cg-RX-API-DMAC10.html) | 2007-10-04 |
Family
ID=8242980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001516508A Pending JP2003506480A (ja) | 1999-08-17 | 2000-08-14 | 急速に溶解する剤形およびその製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7182959B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1202716A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2003506480A (cg-RX-API-DMAC10.html) |
| AU (1) | AU765526B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2380449A1 (cg-RX-API-DMAC10.html) |
| HK (1) | HK1046236A1 (cg-RX-API-DMAC10.html) |
| TR (1) | TR200200313T2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2001012161A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060073188A1 (en) * | 1999-03-31 | 2006-04-06 | Pierre Fabre Medicament | Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic use and method for obtaining same |
| US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
| AR034813A1 (es) * | 2001-07-20 | 2004-03-17 | Novartis Ag | Composiciones farmaceuticas y uso de las mismas |
| EP1414408B1 (en) * | 2001-08-09 | 2006-03-29 | Smithkline Beecham Plc | Composition comprising paroxetine and a pharmaceutically acceptable glycyrrhizinate salt |
| DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
| WO2003068604A1 (en) * | 2002-02-13 | 2003-08-21 | Weibel Michael K | Drug dose-form and method of manufacture |
| ES2199061B1 (es) * | 2002-06-10 | 2005-02-16 | Laboratorios Vita, S.A. | Comprimidos bucodispersables y procedimiento para su obtencion. |
| JP4320217B2 (ja) * | 2002-07-10 | 2009-08-26 | 剤盛堂薬品株式会社 | 鼻炎用経口製剤 |
| US8992980B2 (en) * | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
| US20070092583A1 (en) * | 2003-04-30 | 2007-04-26 | Tim Clarot | Cold remedy composition comprising zinc salts |
| EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
| US20050214365A1 (en) * | 2004-03-24 | 2005-09-29 | Gulf Pharmaceutical Industries | [Instant dissolving tablet composition for loratidine and desloratidine] |
| TWI547431B (zh) * | 2004-06-09 | 2016-09-01 | 史密斯克萊美占公司 | 生產藥物之裝置及方法 |
| US8101244B2 (en) * | 2004-06-09 | 2012-01-24 | Smithkline Beecham Corporation | Apparatus and method for producing or processing a product or sample |
| US20060002594A1 (en) * | 2004-06-09 | 2006-01-05 | Clarke Allan J | Method for producing a pharmaceutical product |
| AR051397A1 (es) | 2004-10-21 | 2007-01-10 | Novartis Ag | Composicion farmaceutica |
| DK1804764T3 (da) * | 2004-10-28 | 2008-09-29 | Pantec Ag | Fremstilling af et hurtigt henfaldende fast præparat ud fra et fast pulver og et frysetörringstrin |
| MX2009006699A (es) * | 2006-12-21 | 2009-06-30 | Mallinckrodt Inc | Composicion y metodo para preparar tabletas oralmente disgregantes que contienen una alta dosis de ingredientes farmaceuticamente activos. |
| CN101686942B (zh) * | 2007-06-27 | 2012-09-26 | 韩美药品株式会社 | 用于快速制备用于口服的崩解剂的方法及其产品 |
| WO2010077878A1 (en) * | 2008-12-15 | 2010-07-08 | Fleming And Company, Pharmaceuticals | Rapidly dissolving vitamin formulation and methods of using the same |
| US20100307542A1 (en) * | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Method of Reducing Surface Oil on Encapsulated Material |
| US9968564B2 (en) | 2009-06-05 | 2018-05-15 | Intercontinental Great Brands Llc | Delivery of functional compounds |
| US20100310726A1 (en) | 2009-06-05 | 2010-12-09 | Kraft Foods Global Brands Llc | Novel Preparation of an Enteric Release System |
| US8859003B2 (en) * | 2009-06-05 | 2014-10-14 | Intercontinental Great Brands Llc | Preparation of an enteric release system |
| AU2010284028A1 (en) * | 2009-08-17 | 2012-03-29 | Waxtabs (Pty) Ltd | Process for manufacturing tablets by using a fluent and settable matrix, and tablets obtained therewith |
| US12186426B2 (en) | 2009-10-30 | 2025-01-07 | Ix Biopharma Ltd. | Solid dosage form |
| US20110105441A1 (en) * | 2009-10-30 | 2011-05-05 | Fmc Corporation | Stable Orally Disintegrating Tablets Having Low Superdisintegrant |
| WO2011053251A1 (en) | 2009-10-30 | 2011-05-05 | Ix Biopharma Pte Ltd | Fast dissolving solid dosage form |
| WO2011087705A2 (en) * | 2009-12-22 | 2011-07-21 | Fmc Corporation | Fine particle croscarmellose and uses thereof |
| BR112012024432A2 (pt) | 2010-03-29 | 2016-05-31 | Ferring Bv | composição farmacêutica de dissolução rápida |
| JO3112B1 (ar) * | 2010-03-29 | 2017-09-20 | Ferring Bv | تركيبة دوائية سريعة التحلل |
| US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
| CA2800251A1 (en) * | 2010-05-25 | 2011-12-01 | David Kossor | Compositions and methods for reduction of mercury toxicity |
| JP6174585B2 (ja) | 2011-09-16 | 2017-08-02 | フェリング ベスローテン フェンノートシャップ | 速溶性医薬組成物 |
| US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
| US9907323B2 (en) | 2015-09-25 | 2018-03-06 | Mead Johnson Nutrition Co. | Infant formula tablets |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311490A (en) * | 1980-12-22 | 1982-01-19 | General Electric Company | Diamond and cubic boron nitride abrasive compacts using size selective abrasive particle layers |
| DE3275121D1 (en) * | 1981-12-11 | 1987-02-19 | Wyeth John & Brother Ltd | Process for preparing solid shaped articles |
| HU203041B (en) * | 1989-03-14 | 1991-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing pharmaceutical compositions of controlled releasing factor containing nifedipin |
| EP0524180B1 (en) * | 1990-04-11 | 1995-04-26 | The Upjohn Company | Taste masking of ibuprofen by fluid bed coating |
| ES2202302T3 (es) * | 1991-05-28 | 2004-04-01 | Mcneil-Ppc, Inc. | Composicion masticable que libera un farmaco. |
| RU2109509C1 (ru) * | 1991-12-24 | 1998-04-27 | Яманути Фармасьютикал Ко., Лтд. | Композиция для буккального введения лекарственного средства и способ ее получения |
| US5686107A (en) * | 1995-01-30 | 1997-11-11 | Fmc Corporation | Chewable pharmaceutical tablets |
| WO1997038679A2 (en) * | 1996-04-16 | 1997-10-23 | Novartis Consumer Health S.A. | Fast disintegrating oral dosage form |
| EP0839526A3 (en) * | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
| US5904937A (en) * | 1997-10-03 | 1999-05-18 | Fmc Corporation | Taste masked pharmaceutical compositions |
| JPH11116466A (ja) * | 1997-10-09 | 1999-04-27 | Ss Pharmaceut Co Ltd | 急速溶解型固形製剤およびその製造法 |
| US6194395B1 (en) * | 1999-02-25 | 2001-02-27 | Orthro-Mcneil Pharmaceutical, Inc. | Cyclodextrin cladribine formulations |
-
2000
- 2000-08-14 TR TR2002/00313T patent/TR200200313T2/xx unknown
- 2000-08-14 JP JP2001516508A patent/JP2003506480A/ja active Pending
- 2000-08-14 EP EP00960455A patent/EP1202716A1/en not_active Withdrawn
- 2000-08-14 HK HK02107469.5A patent/HK1046236A1/zh unknown
- 2000-08-14 AU AU72757/00A patent/AU765526B2/en not_active Ceased
- 2000-08-14 WO PCT/EP2000/007934 patent/WO2001012161A1/en not_active Ceased
- 2000-08-14 CA CA002380449A patent/CA2380449A1/en not_active Abandoned
-
2002
- 2002-02-13 US US10/075,429 patent/US7182959B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2024201739B2 (en) | Dosage forms of controlled release at specific gastrointestinal sites | |
| CN101686942B (zh) | 用于快速制备用于口服的崩解剂的方法及其产品 | |
| RU2204996C2 (ru) | Таблетка, быстро распадающаяся в щечном кармане, и способ ее изготовления | |
| CA1083042A (en) | Pharmaceutical dosage forms for oral administration | |
| US5738875A (en) | Process for preparing solid pharmaceutical dosage forms | |
| Habib et al. | Fast-dissolve drug delivery systems | |
| JP5292145B2 (ja) | 医薬活性剤の経口デリバリーデバイスの調製のための射出成形法 | |
| US7276252B2 (en) | Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form | |
| TW402561B (en) | Process for the preparation of a solid rapidly disintegrating dosage form and the dosage form prepared thereby | |
| AU632770B2 (en) | Solid encapsulated medicament and process and apparatus for preparing same | |
| CA2131089C (en) | Method of producing porous delivery devices | |
| JP3296412B2 (ja) | 成型製剤及びその製法 | |
| RU2005114465A (ru) | Быстро распадающаяся форма дозировки, высвобождающая действующие ингредиенты в ротовую полость или полости тела | |
| JP2003506480A (ja) | 急速に溶解する剤形およびその製造方法 | |
| CZ301249B6 (cs) | Rychle dispergovatelná pevná dávková forma | |
| CN112839637A (zh) | 固体剂型生产 | |
| KR101216301B1 (ko) | 경구투여용 속용 제제의 제조 방법 및 그 제조를 위한 약제포장장치 | |
| JPS638327A (ja) | ペレツトから構成されるモ−ルデイング | |
| Kushwaha et al. | A review on fast dissolving formulation technologies | |
| EP2361614A2 (en) | Fast dissolving oral tablets and method for production thereof | |
| CN102424151B (zh) | 一种制备用于口服的快速崩解剂的包装机 | |
| KR100355060B1 (ko) | 고체약제투여형을제조하는방법 | |
| JPH10316556A (ja) | 安定な口腔内崩壊型揮散性薬物含有固形剤およびその製造法 | |
| JPH0132205B2 (cg-RX-API-DMAC10.html) | ||
| Nepolean et al. | Innovations in Orally Disintegrating Tablets Technology: Formulation Principles, Taste Masking Mechanisms, and Biopharmaceutical Considerations |